Good to see we getting Finance News coverage
http://www.finnewsnetwork.com.au/CompanyReports/Imugene-Limited/Imugene-Announces-PD|||1-Cancer-Vaccine-Development-Update
Imugene Announces PD-1 Cancer Vaccine Development Update
23 Jul 2018 10:13 AM
• New PD-1 cancer vaccine named KEY-Vaxx
• Phase 1 planning well advanced
• Preclinical results in validated models of colorectal (colon) cancer
demonstrate inhibitory cancer growth activity
MELBOURNE Australia 23 July 2018: Imugene Limited (ASX:IMU), a clinical stage immuno-oncology company is pleased to announce a development update of its newly acquired PD-1 cancer vaccine from Ohio State University. The check-point inhibitor cancer vaccine named KEY-Vaxx, demonstrates superior cancer growth inhibition compared with an industry-standard monoclonal antibody in validated models of colorectal (colon) cancer (CT26).
Ann: PD-1 cancer vaccine development update, page-43
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 4.9¢ | 4.8¢ | $424.8K | 8.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 69 | 8622849 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 1925890 | 9 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |